Aura Biosciences grants Kratz 100,885 RSUs, options
Erica Kratz’s inducement RSUs and options now vest starting Sept. 15, 2027, leaving her with 100,885 shares and 199,115 options.
Rhea-AI Filing Summary
Aura Biosciences, Inc. (AURA) reported that Chief Regulatory & Quality Officer Erica Kratz received equity awards on 2026-09-01. She was granted 100,885 restricted stock units as an inducement award, each representing one share of common stock, vesting in four substantially equal annual installments starting on September 15, 2027, subject to continued service. She also received a stock option for 199,115 shares of common stock at an exercise price of $7.43 per share, vesting 25% on August 10, 2027 with the remainder vesting pro rata in 36 monthly installments, and expiring on September 1, 2036. Following these awards, the filing reports holdings of 100,885 common shares and 199,115 stock options directly owned.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 300,000 shares
Grant/Award
2 txns
Insider
Kratz Erica
Role
Chief Reg. & Quality Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 199,115 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 100,885 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 199,115 contracts (Direct);
Common Stock — 100,885 shares (Direct)
Footnotes (2)
- F1. These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.
- F2. The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Key Figures
RSUs granted: 100,885 RSUs
Option shares granted: 199,115 shares
Option exercise price: $7.43 per share
+3 more
6 metrics
RSUs granted
100,885 RSUs
Inducement award to Chief Reg. & Quality Officer on 2026-09-01
Option shares granted
199,115 shares
Stock Option (Right to Buy) granted on 2026-09-01
Option exercise price
$7.43 per share
Exercise price for 199,115-share option grant expiring 2036-09-01
Option expiration date
September 1, 2036
Expiration of stock option granted to Erica Kratz
Common shares held after award
100,885 shares
Direct common stock holdings following RSU grant
Options held after award
199,115 options
Direct option holdings following option grant
Key Terms
restricted stock unit, inducement award, vesting, Stock Option (Right to Buy)
4 terms
restricted stock unit financial
"These securities represent an inducement award granted pursuant to a restricted stock unit"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
inducement award financial
"These securities represent an inducement award granted pursuant to a restricted stock unit"
An inducement award is a special cash or equity payment given to a new hire—often an executive or key employee—outside the company’s regular pay plans to persuade them to join. Think of it like a signing bonus that can align the new person’s goals with shareholders but also represents a cost and can reduce existing owners’ percentage of the company, so investors watch these awards for their impact on ownership and future performance.
vesting financial
"These RSUs vest in four substantially equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
FAQ
What insider transactions did AURA report for Erica Kratz on this Form 4?
The company reported that Erica Kratz received a grant of 100,885 restricted stock units and a stock option for 199,115 shares of common stock at an exercise price of $7.43 per share on 2026-09-01.
How many Aura Biosciences (AURA) RSUs were granted to Erica Kratz?
She was granted 100,885 restricted stock units as an inducement award. Each RSU represents the right to receive one share of AURA common stock, vesting in four substantially equal annual installments starting on September 15, 2027, subject to continued service.
What are the terms of the stock options granted to Erica Kratz by AURA?
She received a stock option covering 199,115 shares of AURA common stock with an exercise price of $7.43 per share, expiring on September 1, 2036. 25% vest on August 10, 2027, with the remainder vesting pro rata in 36 monthly installments, subject to continued service.
When do Erica Kratz’s AURA RSUs start vesting?
The RSUs are scheduled to start vesting on September 15, 2027. They vest in four substantially equal annual installments, and each installment is subject to Ms. Kratz’s continued service with Aura Biosciences as of the relevant vesting date.
What are Erica Kratz’s reported AURA holdings after these transactions?
Following the reported awards, her direct holdings shown in the filing are 100,885 shares of AURA common stock and 199,115 stock options, each option exercisable for one share of common stock, subject to their respective vesting schedules.
AI-generated analysis. How Rhea-AI works. Not financial advice.
